Which of the following statements about pegfilgrastim is true?
Correct Answer: It decrease the risk of neutropenia in patients on anti cancer therapy
Description: PEGFILGRASTIM:- Long acting granulocyte colony stimulating factor (GCSF). It is used along with anticancer drug to decrease neutropenia. Commonly given by SC route. Drug ending with GRASTIM are granulocytes stimulator. Drug ending with GRAMOSTIM are granulocyte monocyte stimulator. Eg:- SARGRAMOSTIM.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now